Backgrounds/Aims: Aggressive surgical resection for hepatic metastasis is validated, however, concomitant liver and lung metastasis in colorectal cancer patients is equivocal. Methods: Clinicopathologic data from January 2008 through December 2012 were retrospectively reviewed in 234 patients with colorectal cancer with concomitant liver and lung metastasis. Clinicopathologic factors and survival data were analyzed. Results: Of the 234 patients, 129 (55.1%) had synchronous concomitant liver and lung metastasis from colorectal cancer and 36 (15.4%) had metachronous metastasis. Surgical resection was performed in 33 patients (25.6%) with synchronous and 6 (16.7%) with metachronous metastasis. Surgical resection showed better overall survival in both groups (synchronous, p=0.001; metachronous, p=0.028). In the synchronous metastatic group, complete resection of both liver and lung metastatic lesions had better survival outcomes than incomplete resection of two metastatic lesions (p=0.037). The primary site of colorectal cancer and complete resection were significant prognostic factors (p=0.06 and p=0.003, respectively). Conclusions: Surgical resection for hepatic and pulmonary metastasis in colorectal cancer can improve complete remission and survival rate in resectable cases. Colorectal cancer with concomitant liver and lung metastasis is not a poor prognostic factor or a contraindication for surgical treatments, hence, an aggressive surgical approach may be recommended in well-selected resectable cases. 
INTRODUCTION
The liver is the most frequent site of metastatic colorectal cancer, and metastatic lesions from colorectal cancer are frequently detected in the lungs, bones, and brain. 1, 2 As surgical managements such as operative equipment innovation, operation strategy, and perioperative management have advanced, morbidity and mortality associated with surgical resection are reduced to acceptable levels.
Since the first report of liver or lung metastasectomy due to colorectal cancer, 3 surgical resection of liver and lung metastatic lesions is considered the only therapeutic option for long-term survival. 4 In addition, perioperative chemotherapy improves the resectability of metastasectomy with minimal safety margins, which is an accepted standard procedure that is frequently performed worldwide. 5 A safety resection margin of ＞1 cm, or a 3-mm margin, is widely used for surgical resection of metastasis of colorectal cancer. 6, 7 Several clinical guidelines recommend surgical resection for synchronous or metachronous resectable metastatic lesions before or after systemic chemotherapy. 2, 8 However, the role of surgical resection in concomitant liver and lung metastasis is not clearly defined, and aggressive surgical resection may be a contributing factor in improvement of survival outcomes in patients with confirmed concomitant liver and lung metastasis. 9 The aim of this study was to evaluate the efficacy of surgical resection in concomitant synchronous or 
MATERIALS AND METHODS

Patient selection
RESULTS
Patient characteristics
The age of patients with synchronous metastasis was There was no postoperative mortality within 30 days after operation (Table 2 ). Recurrence after surgical resection was 63.6% and 83.3% in the synchronous and metachronous groups, respectively. Survival analysis was performed using the Kaplan-Meier method and log-rank test.
In the synchronous metastasis group, the resection group had statistically better survival, as compared to the non-resection group (p＜0.001). Furthermore, complete resection of both liver and lung metastasis had significantly better survival than the incomplete resection group (p=0.037).
Additionally, in the metachronous group, the resection group had significantly better survival, as compared to the non-resection group (p=0.028) (Fig. 2) .
Prognostic factors
Multivariate analysis for prognostic factors of overall survival was performed using previously known prognostic factors and potential clinical markers. Rectal primary cancer was marginally significant (p=0.06, hazard ratio (HR)=0.988-2.318), and incomplete surgical resection for metastatic lesions was most significant (p=0.003, HR=1.477-6.441) for predicting poor outcomes in concomitant liver and lung metastasis from colorectal cancer ( Table 3) .
DISCUSSION
Colorectal cancer leads to metastatic disease in 60% of cases, with frequent involvement of the liver, lungs, or both. 5 Following several reports of promising results after surgical resection of liver metastasis from colorectal cancer, the paradigm has shifted from limited indication for hepatic resection to an active surgical approach. 1, 4 Currently, the only absolute contraindication is the inability to obtain a tumor-free margin and maintain adequate liver function. Surgical resection is the only way to achieve long-term survival in patients with colorectal cancer liver metastases; 10 and several comparative studies have revealed that surgical resection shows better survival outcomes, as compared to systemic chemotherapy alone.
11-13
Although several studies have explored optimal treatment strategies, there are still limitations for specific guidelines in a patient with synchronous or metachronous concomitant liver and lung metastasis from colorectal cancer. 9, 10 Treatment strategy differs between institutions Fig. 2 . Survival analysis for synchronous and metachronous metastasis from colorectal cancer. Survival analysis using the Kaplan-Meier method and log-rank test (A) in the synchronous metastasis group, the resection group showed significantly better survival compared to the non-resection group. (B) Complete resection for both liver and lung metastasis had significantly better survival compared to the incomplete resection group. (C) In the metachronous group, the resection group showed significantly better survival compared to the non-resection group. [14] [15] [16] In this study, the pattern of The prognostic factors for liver and lung metastasis from colorectal cancer in terms of CEA, rectal primary cancer, bilateral lung metastasis, and multiple metastases have been recently reported. 14, 17, 18 In particular, complete surgical resection of both liver and lung metastasis is the most significant prognostic factor for patients with concomitant liver and lung metastasis with colorectal cancer, according to a study on the synchronism of liver and lung metastasis. 9 The resectability of liver and lung metastasis has gradually increased due to the progress in surgical skill and technique, and improvement of perioperative management. Recent advances in molecular biology have also offered new prognostic factors, e.g., KRAS, BRAF, NRAS, and PIK3CA mutations, for patients with metastatic colorectal cancer in the era of precision medicine. 19 This study has several limitations in terms of retrospective design, single-center study, and small study population. The heterogeneous clinical status of the enrolled population is another limitation. However, the evidence regarding the clinical situation for concurrent liver and lung metastasis in colorectal cancer is relatively rare and the strategy for this situation is not yet established.
Therefore, this study increases our current understanding of concurrent liver and lung metastasis in colorectal cancer.
In conclusion, the results of this study indicated that the resection of hepatic and pulmonary metastases from colorectal cancer is safe and can offer long-term survival to selected patients. Surgery should be considered only if resection of all metastatic sites are potentially curative.
Furthermore, resections should be as limited as possible to allow for repeat resections for eventual disease recurrence.
